The effect of dexmedetomidine on the inflammatory response in children undergoing repair of congenital heart disease: a randomized controlled clinical trial

References

• Hall RI. Cardiopulmonary bypass and the systemic inflammatory response: effects on drug action. J Cardiothorac Vasc Anesth. 2002;16:83–98.
   PubMed Web of Science ®Google Scholar
• Wan S, J-L L, Vincent J-L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676–692.
   PubMed Web of Science ®Google Scholar
• Cuccurullo L, Accardo M, Agozzino L, et al. Ultrastructural pathology of pediatric myocardium in acute ischemia: bioptic study before and after treatment with cardioplegic solution. Ultrastruct Pathol. 2006;30:453–460.
   PubMed Web of Science ®Google Scholar
• Gaynor JW, Wernovsky G, Jarvik GP, et al. Patient characteristics are important determinants of neurodevelopmental outcome at one year of age after neonatal and infant cardiac surgery. J Thorac Cardiovasc Surg. 2007;133:1344–1353.e3.
   Web of Science ®Google Scholar
• Brix‐Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand. 2001;45:671–679.
   PubMed Web of Science ®Google Scholar
• Manrique AM, Vargas DP, Palmer D. et al. 2020, The effects of cardiopulmonary bypass following pediatric cardiac surgery. Munoz RA, Morell VO, Vetterly CG(Eds.), . Crit Care Child Hear Dis
   Google Scholar
• Pasquali SK, Li JS, He X, et al. Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. Pediatrics. 2012;129:e385–91.
   Web of Science ®Google Scholar
• Poyrazoğlu HH, Duman Z, Demir Ş, et al. Investigating the impacts of preoperative steroid treatment on tumor necrosis factor-alpha and duration of extubation time underwent ventricular septal defect surgery. Balkan Med J. 2016;33:158–163.
   Web of Science ®Google Scholar
• Durandy Y. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population. Artif Organs. 2014;38:11–18.
   PubMed Web of Science ®Google Scholar
• Craciun EM, Altfelder F, Kuss N, et al. Anti-inflammatory effects of selected drugs on activated neonatal and adult neutrophils. Scand J Clin Lab Invest. 2013;73:407–413.
   PubMed Web of Science ®Google Scholar
• Bach F, Grundmann U, Bauer M, et al. Modulation of the inflammatory response to cardiopulmonary bypass by dopexamine and epidural anesthesia. Acta Anaesthesiol Scand. 2002;46:1227–1235.
   Web of Science ®Google Scholar
• Greilich PE, Brouse CF, Whitten CW, et al. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of ϵ-aminocaproic acid and aprotinin. J Thorac Cardiovasc Surg. 2003;126:1498–1503.
   PubMed Web of Science ®Google Scholar
• Welters ID, Feurer M-K, Preiss V, et al. Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth. 2011;106:172–179.
   PubMed Web of Science ®Google Scholar
• Brull DJ, Sanders J, Rumley A, et al. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Heart. 2002;87:252–255.
   PubMed Web of Science ®Google Scholar
• Kambam J, Meszaros R, Merrill W, et al. Prophylactic administration of histamine 1 and histamine 2 receptor blockers in the prevention of protamine-related haemodynamic effects. Can J Anaesth. 1990;37:420–422.
   Google Scholar
• Allan CK, Newburger JW, McGrath E, et al. The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass. Anesth Analg. 2010;111:1244–1251.
   Web of Science ®Google Scholar
• Straub RH, Herrmann M, Berkmiller G, et al. Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control. J Neurochem. 1997;68:1633–1639.
   PubMed Web of Science ®Google Scholar
• Sukegawa S, Inoue M, Higuchi H, et al. Proceedings of the American Society of Anesthesiologists Annual Meeting 2011, A1590
   Google Scholar
• Seghaye M-C, Duchateau J, Grabitz RG, et al. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg. 1996;61:1205–1211.
   Web of Science ®Google Scholar
• Ueki M, Kawasaki T, Habe K, et al. The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass. Anaesthesia. 2014;69:693–700.
   Web of Science ®Google Scholar
• Bulow NMH, Colpo E, Pereira RP. et al. Dexmedetomidine decreases the inflammatory response to myocardial surgery under mini-cardiopulmonary bypass. . Brazilian J Med Biol Res
   Google Scholar
• Zhou H, Zhou D, Lu J, et al. Effects of Pre–Cardiopulmonary Bypass Administration of Dexmedetomidine on Cardiac Injuries and the Inflammatory Response in Valve Replacement Surgery With a Sevoflurane Postconditioning Protocol: A Pilot Study. J Cardiovasc Pharmacol. 2019;74:91.
   Web of Science ®Google Scholar
• Mukhtar AM, Obayah EM, Hassona AM. The use of dexmedetomidine in pediatric cardiac surgery. LWW. 2006;103:52–6.
   Google Scholar
• Roekaerts PM, Prinzen FW, Willigers HM, et al. The effects of alpha2-adrenergic stimulation with mivazerol on myocardial blood flow and function during coronary artery stenosis in anesthetized dogs. Anesthesia Analg. 1996 Apr 1;82(4):702–711.
   Web of Science ®Google Scholar
• Gupta P, Whiteside W, Arash Sabati TM, et al. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease. Pediatr Crit Care Med. 2012;13(6):660–666.
   Web of Science ®Google Scholar
• Pichot C, Géloën A, Ghignone M, et al. Alpha-2 agonists to reduce vasopressor requirements in septic shock? Med Hypotheses. 2010 Dec 1;75(6):652–656.
   Web of Science ®Google Scholar
• Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med. 2018;44(6):925–928.
   PubMed Web of Science ®Google Scholar
• Ji F, Li Z, Nguyen H, et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013;127:1576–1584.
   Web of Science ®Google Scholar
• Geng J, Qian J, Cheng H, et al. The influence of perioperative dexmedetomidine on patients undergoing cardiac surgery: a meta-analysis. PLoS One. 2016;11(4).
   Web of Science ®Google Scholar